Results for tag: "Lung Marker"

Biomarkers are biological molecules that can be used to measure and monitor the progression of a disease or condition. Lung markers are a type of biomarker used to measure and monitor lung diseases, such as asthma, COPD, and lung cancer. These markers can be used to diagnose and monitor the progression of the disease, as well as to assess the effectiveness of treatments. Lung markers are typically measured in the blood, urine, or exhaled breath. Commonly used lung markers include surfactant proteins, cytokines, and other inflammatory markers. These markers can be used to detect the presence of a disease, as well as to monitor its progression. The lung marker market is a rapidly growing segment of the biomarker market. Companies in this market are focused on developing and commercializing new and innovative lung markers for the diagnosis and monitoring of lung diseases. Examples of companies in this market include AbbVie, AstraZeneca, and Roche. Show Less Read more